Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver
about
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansAn apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphismsAntagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cellsLow density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteinsApolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemiaNew Era of Lipid-Lowering DrugsWhy Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Increased response to cholesterol feeding in apolipoprotein C1-deficient miceLoss-of-function mutations in APOC3, triglycerides, and coronary diseaseAmyloid triangles, squares, and loops of apolipoprotein C-III.Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptorsHigh density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levelsHeterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivoMetabolism of very low density lipoproteins after cessation of cholesterol feeding in rabbits. A factor potentially contributing to the slow regression of atheromatous plaques.Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma TriglyceridesMultilocus genetic determinants of LDL particle size in coronary artery disease familiesApolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Ultrastructural studies of the portal transport of fat in chickens.Genome-Wide Association Study Reveals Four Loci for Lipid Ratios in the Korean Population and the Constitutional Subgroup.ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout miceLipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities StudyD25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetesEffect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With LipodystrophyAromatic residues in the C-terminal helix of human apoC-I mediate phospholipid interactions and particle morphology.Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein ClIn the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.Lipid disturbances in psoriasis: an update.Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
P2860
04c90d13c929569fecb32e58e5be2b60e2bc94f36dd95bd8bc04451df5cc280b49c5ecc74a3c1b369c6c7bec22a4874d68b478bd680d308768e76c09bd8bdfbd1b0ca8d0e7c0b5106cc4aa59d873dc58d1a7988c2718a2850b266fc0365e47d9852d6987de97179c67d214ff63915ae75e5cde5a01841bc6ed9fb37b6be838eac8b324da8279b17e8b57fc1dfd3cbaa3a746b60c2b85eaa8ab9309dc9af25a31
P248
Q21283798-FF865798-CFD8-42EB-AF85-31699B9B5B9AQ24562942-8E33205B-96C1-43AF-9169-5B1F267D6311Q24606324-FC010F97-1A27-472F-BF10-5BCAB239A853Q24609758-5A94F1B3-2E3D-440F-A57E-C0E5FACEC1F6Q24633209-662D71FE-0D83-4DD2-A857-7A04D107300AQ28072298-3653AC6E-002F-4619-929B-9A30BEB9EBAFQ28077776-66377FD1-93A1-404A-BF09-1BF059DBA8F4Q28587768-FB257016-660E-439A-AF3C-1FCD9A5D6E9CQ30408720-BBC4EC68-6C5E-4ABB-B4E4-840477F0F151Q33684952-C42A980F-8C20-486B-BE3A-7BA5A3575E62Q33848680-E98EF033-547E-40B9-B2A7-1521FD69C978Q33907635-0D24A210-2850-46ED-8415-3A61D2A66984Q33958622-93235FB2-973A-44F8-ABC2-AB060B3654A7Q34094985-1A8293CE-F57E-47E8-9EF1-DDCBFB5C3D70Q34140679-77278B64-A83A-4A6F-A0DC-8C29CE9598B0Q34188082-4C9A0F43-9AF7-4257-BEE8-66AB4380ABBDQ34205047-32A18FA8-C253-4B0F-9894-4B44E15D62EAQ34546130-35DCAB07-4832-4B8A-A60C-42CA305106A5Q34573231-5A96C696-C0F7-43BC-A290-F344F68998EEQ35608640-7C616DC7-F004-44A3-B2D9-4BBE78169BEFQ35860314-B5786E7F-5CD5-49DF-A236-6AAA5A2BBFF4Q35881504-1CA903F9-89EE-4EEF-B32D-DD1DA2FA2E92Q35915137-18037446-866D-4749-9786-74CEE6D077CAQ36050967-51B08DAB-8103-463C-84B8-787FD8AF21CFQ36238272-317A32B7-DA7A-4E55-894F-ADC05F59DF93Q36462065-10BCB248-73B6-46D4-BBC9-E5B9115C9E0FQ36517373-D9774755-7157-4FB5-8A17-2321AFC75B9AQ36528525-D5FE02DF-E863-44FE-A776-3BF29D464E29Q36843331-CE2E73B6-5C5E-4B3F-A6F0-29F6268D8299Q36935534-F6CE9CB5-254F-4594-99FF-FA2F56D8B2C7Q37222415-D9ACB84B-49F8-4A60-BED5-F955F391C522Q37358494-F86E26BE-2670-46EE-A10B-E06E8AC8FD95Q37361432-D9BE2DA2-1446-42FF-8DB9-A159A5078D96Q37516902-28EB18B0-0F79-446E-924A-EE3B6D493377Q37779736-0F8983B4-0E5B-44DF-8275-5E9C496289C0Q38682093-7E99C98F-20F4-426A-BEF1-EA1F3BE375D2Q39614082-F65D2C5D-B548-4D30-A741-A6565C212EC6Q40229506-359202DA-CBFA-4CCA-B88D-16C00E0C1C5FQ40301333-7FFC292E-53EA-4ADB-A7DA-C9D8CA7C5400Q40303557-7AA99013-861D-4A5C-92A8-B35D031AA93E
P2860
Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver
description
1985 nî lūn-bûn
@nan
1985 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@ast
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en-gb
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@nl
type
label
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@ast
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en-gb
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@nl
prefLabel
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@ast
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en-gb
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@nl
P921
P3181
P1476
Inhibitory effects of C apolip ...... ants by the perfused rat liver
@en
P2093
P304
P3181
P407
P577
1985-05-01T00:00:00Z